Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX), the developer of DehydraTECH™, a proprietary drug delivery technology that improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly. READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-demonstration-of-improved-oral-delivery-for-antiviral-drugs-with-the-stock-day-podcast-lxrp-december-8-2020/ Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Dec 8, 2020

Embed this episode

Attribution link and audio player

Ready to play

Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast

0:00 11:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 11 minutes long.

When was this Stock Day Media episode published?

This episode was published on December 8, 2020.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!